Prelude Therapeutics
PRLD
#8532
Rank
ยฃ0.19 B
Marketcap
ยฃ2.47
Share price
-0.77%
Change (1 day)
93.59%
Change (1 year)

Earnings for Prelude Therapeutics (PRLD)

Earnings in 2026 (TTM): -ยฃ50.44 Million

According to Prelude Therapeutics's latest financial reports the company's current earnings are ยฃ22.42 Million. In 2025 the company made an earning of -ยฃ79.94 Million, an increase over its 2024 earnings that were of -ยฃ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prelude Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ50.44 Million-36.9%
2025 -ยฃ79.94 Million-25.16%
2024 -ยฃ0.11 Billion5.62%
2023 -ยฃ0.11 Billion7.07%
2022 -ยฃ94.44 Million8.62%
2021 -ยฃ86.95 Million93.55%
2020 -ยฃ44.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 131.67%๐Ÿ‡บ๐Ÿ‡ธ USA